Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection.

Zhila MaghbooliMohammad Ali SahraianMehdi EbrahimiMarzieh PazokiSamira KafanHedieh Moradi TabrizAzar HadadiMahnaz MontazeriMehrad NasiriArash ShirvaniMichael F Holick

Published in: PloS one (2020)

Therefore, it is recommended that improving vitamin D status in the general population and in particular hospitalized patients has a potential benefit in reducing the severity of morbidities and mortality associated with acquiring COVID-19.

Keyphrases

coronavirus disease
sars cov
cardiovascular events
risk factors
human health
emergency department
cardiovascular disease